Category: Joint ventures/collaborations
-
Institutions to Apply AI Models to Type 1 Diabetes
A children’s hospital and diabetes research center are evaluating techniques using artificial intelligence to better identify and manage the care of people with type 1 diabetes.
-
Cancer Center to Test Focused Radiation Therapy
MD Anderson Cancer Center is testing new radiation treatments for cancer designed to reduce adverse side effects of conventional radiation therapy.
-
Pharma Company Seeking Digital Tech Partners
Drug maker AstraZeneca is seeking partners to develop solutions with digital technology to accelerate clinical trials and improve health outcomes for patients.
-
Engineered Immune Cells to be Explored for Solid Tumors
A cancer research center and biotechnology company will examine genetically engineered immune system cells as possible treatments for solid tumor cancers.
-
Broad Inst., Intel Make Genomics Software Open-Source
A new release of software that speeds and streamlines analysis of genomic sequencing variations is being released under an open-source license by the Broad Institute.
-
Liquid Biopsy Company Gains $360M for Cancer Sequencing
A company using blood tests to diagnose cancer is receiving a $360 million investment for its campaign to sequence DNA from 1 million people at high risk of cancer.
-
Trial to Examine Immune System Workings
Unlike conventional clinical studies testing a particular treatment, this trial aims to explore in more detail the body’s interactions with a class of drugs, in this case vaccines.
-
Growing Engineered Algae Outdoors Shown Feasible, Safe
A test of cultivating genetically engineered algae in outdoor tanks shows the production technique is feasible and does not pose risks to native algae populations.
-
23andMe, Grünenthal Partner on Pain Genetics
A personal genetics company in Silicon Valley is collaborating with a German pharmaceutical company to better understand the relationship between genetics and pain.
-
Neural Technology Research Centers Launched
Research centers for accelerating new technologies that tackle nervous system disorders are opening at two universities in the U.S., with industry partners.